BUSYMING (01768) grants a total of 1,618,800 awards.
BUSYMING (01768) announced that on September 21, 2026, the Company granted a total of 1,618,800 awards to 185 employee participants under the 2026 H Share Award Scheme, subject to acceptance by the incentive recipients. Each award represents a conditional right to receive one award share, subject to the fulfillment of certain terms and conditions of the grant. The total number of award shares involved in the granted awards is 1,618,800 shares, representing approximately 0.74% of the total number of issued shares as of the date of this announcement (excluding treasury shares (if any)).
BUSYMING (01768) announced that on September 21, 2026, the Company granted a total of 1,618,800 awards to 185 employee participants under the 2026 H Share Award Scheme, subject to acceptance by the grantees. Each award represents a conditional right to receive one award share, subject to the fulfillment of certain terms and conditions of the award grant. The total number of award shares involved in the granted awards is 1,618,800 shares, representing approximately 0.74% of the total number of issued shares as of the date of this announcement (excluding treasury shares, if any).
Related Articles

Genimous Technology (000676.SZ) plans to launch a 2026 restricted stock incentive plan.

Viking Therapeutics (VKTX.US) Weight-Loss Drug Delivers Good News: Halving Dosing Frequency Still Maintains 97% Weight Loss, Stock Price Once Soared Nearly 50% in Pre-Market Trading

Dongguan Development (000828.SZ) subsidiary plans to invest 75 million yuan in Tongzhi Fund.
Genimous Technology (000676.SZ) plans to launch a 2026 restricted stock incentive plan.

Viking Therapeutics (VKTX.US) Weight-Loss Drug Delivers Good News: Halving Dosing Frequency Still Maintains 97% Weight Loss, Stock Price Once Soared Nearly 50% in Pre-Market Trading

Dongguan Development (000828.SZ) subsidiary plans to invest 75 million yuan in Tongzhi Fund.






